| Literature DB >> 35011827 |
Luísa Bandeira Lopes1,2, Catarina Calvão1,2, Filipa Salema Vieira1,2, João Albernaz Neves2,3, José João Mendes2,4, Vanessa Machado2,4, João Botelho2,4.
Abstract
Dental caries is the most common non-communicable disease in children with significant aesthetic, functional, and quality of life deterioration. Depending on the depth, two approaches may be considered in primary dentition: vital pulp therapy (VPT) or non-vital therapy (NPT). This umbrella review aimed to critically assess the available systematic reviews (SRs) on VPT and NPT. An electronic database search was conducted (PubMed, Embase, Scopus, Cochrane, Web of Science, and LILACS) until June 2021. The Risk of Bias (RoB) of SRs was analyzed using the Measurement Tool to Assess SRs criteria 2 (AMSTAR2). From 272 entries, 33 SRs were included. Regarding the methodological quality, three studies were critically low, nine low, seventeen moderate, and six were rated as high quality. The quality of evidence produced by the available SRs was moderate. Future high standard SRs and well-designed clinical trials are warranted to better elucidate the clinical protocols and outcomes of VPT and NPT.Entities:
Keywords: dental medicine; endodontics; oral health; pediatric dentistry; systematic review; umbrella review
Year: 2021 PMID: 35011827 PMCID: PMC8745069 DOI: 10.3390/jcm11010085
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1PRISMA flowchart of included studies.
Characteristics of included studies.
| Authors (Year) | N | Search Period | Interventions | Quality Assessment Tool | Sample | Method of Analysis | Outcomes | AMSTAR2 Score * | Funding |
|---|---|---|---|---|---|---|---|---|---|
| Ansari et al. (2018) [ | 17 | Up to November 2017 | Laser vs. | None | 15 NRSI and 2 case reports | SR & MA | Success rate (clinical and radiographic) | Critically Low | NI |
| Asgary et al. (2014) [ | 4 | Up to June 2013 | MTA vs. FS in pulpotomy | Modified van Tulder list [ | 4 RCTs | SR & MA | Success rate (clinical) | Moderate | NI |
| Barcelos et al. (2011) [ | 2 | Up to May 2017 | ZOE vs. No ZOE pulpectomy | Jadad’s scale [ | 2 RCTs | SR | Success rate (clinical and radiographic) | Moderate | NI |
| Bossu et al. (2020) [ | 41 | Up to October 2019 | MTA vs. Biodentine vs. FS vs. FC in pulpotomy | Cochrane | NI | SR | Success rate (clinical and radiographic) | Low | Self-funded |
| Chandran et al. (2020) [ | 14 | Unclear (up to 2020) | Laser pulpotomy vs. conventional pulpotomy | Cochrane | 14 RCTs | SR & MA | Success rate (clinical and radiographic) | High | NI |
| Chugh et al. (2020) [ | 11 | Up to March 2020 | Rotary vs. hand root canal instrumentation | ROB 2.0 [ | 11 RCTs | SR & MA | Success rate (clinical) | High | NI |
| Coll et al. (2017) [ | 87 | Since 1990 | Indirect Pulp Therapy vs Direct pulp capping Vs Pulpotomy | ROB | - | SR & MA | Success rate (clinical and radiographic) | High | NR |
| Coll et al. (2020) [ | Unclear (up to 2020) | Pulpectomy rate success in teeth with and without root resorption, | ROB | - | SR & MA | Success rate (clinical and radiographic) | High | NR | |
| De Coster et al. (2013) [ | 7 | Unclear (up to 2012) | Laser vs. conventional pulpotomy procedures | Dutch Cochrane Collaboration tool | 5 RCTs and 2 Case series | SR | Success rate (clinical) | Critically Low | NI |
| Duarte et al. (2020) [ | 6 | Up to | Lesion sterilization and tissue repair (LSTR) pulpotomy vs. pulpectomy | Cochrane | 6 RCTs | SR & MA | Success rate (clinical and radiographic) | Moderate | Research Grant |
| Gadallah et al. (2018) [ | Up to March 2018 | Pulpotomy Vs pulpectomy | Cochrane | 4 RCTs | SR & MA | Success rate (clinical and radiographic) | Low | Self-funded | |
| Garrocho Rangel et al. (2019) [ | 12 | Up to December 2019 | Direct pulp capping with no carious or small carious exposure of pulpt | Criteria developed by the authors | 12 RCTs | SR | Success rate (clinical and radiographic) | Moderate | Partially by Research Grant |
| Ghajari et al. (2008) [ | 8 | Up to March 2008 | MTA vs. FC in pulpotomy | Jadad’s scale [ | 8 RCTs | SR & MA | Success rate (clinical and radiographic) | Moderate | NI |
| Junior et al. (2019) [ | 9 | Up to August 2017 | Biodentine vs. MTA in pulpotomy | Cochrane | 7 RCTs and 2 NRSI | SR & MA | Success rate (clinical and radiographic) | High | NI |
| Lin et al. (2014) [ | 37 | Up yo December 2012 | MTA vs. Biodentine vs. FS vs. FC vs. Laser in pulpotomy | Criteria developed by the authors | 37 RCTs | SR and Network MA | Success rate (clinical and radiographic) | Moderate | Research Grant |
| Manchanda et al. (2020) [ | 13 | Up to January 2019 | Rotary vs. hand root canal instrumentation | ROB 2.0 [ | 13 RCTs | SR & MA | Success rate (clinical and radiographic) | Low | NI |
| Marghalani et al. (2014) [ | 20 | Up to May 2013 | MTA vs. FC in pulpotomy | Cochrane | 20 RCTs | SR & MA | Success rate (clinical and radiographic) | Moderate | NI |
| Nagendrababu et al. (2018) [ | 8 | Up to October 2017 | MTA vs. Biodentine in pulpotomy | ROB 2.0 [ | 8 RCTs | SR & MA | Success rate (clinical and radiographic) | Moderate | NI |
| Najjar et al. (2019) [ | 15 | Up to January 2018 | CH/iodoform vs ZOE in pulpectomy | CONSORT [ | 15 RCTs | SR & MA | Success rate (clinical and radiographic) | Moderate | Self-funded |
| Nematollahi et al. (2019) [ | 12 | Up to September 2017 | Laser vs no laser pulpotomy | Jadad’s scale [ | 12 RCTs | SR & MA | Success rate (clinical and radiographic) | Low | Self-funded |
| Nuvvula et al. (2018) [ | 20 | Up to January 2017 | FS vs. other agents in pulpotomy | Fuks and Papagiannoulis criteria [ | NI | SR | Success rate (clinical and radiographic) | Low | Self-funded |
| Peng et al. (2007) [ | 11 | Up to May 2006 | FC vs. FS in pulpotomy | Jadad’s scale [ | 4 RCTs, 4 CCTs, 3 retrospective studies | SR & MA | Success rate (clinical and radiographic) | Moderate | NI |
| Pintor et al. (2016) [ | 2 | Up to May 2013 | Smear layer removal vs non removal | Cochrane | 2 RCTs | SR | Success rate (clinical and radiographic) | Moderate | NI |
| Pozos-Guillen et al. (2016) [ | 7 | NI | Clinical efficacy of intracanal irrigants in pulpectomy | Criteria developed by the authors | 7 RCTs | SR & MA | Success rate (clinical) | Moderate | Research Grant |
| da Rosa et al. (2019) [ | 17 | Up to February 2018 | CH vs. no-CH as pulp capping | Cochrane | 14 RCTs and 1 retrospective study on primary teeth | SR & MA | Success rate (clinical) | Moderate | Research Grant |
| Schwendicke et al. (2016) [ | 11 | Up to April 2015 | Comparing direct pulp capping materials | Cochrane | 11 RCTs | SR & MA | Success rate (clinical and radiographic) | Moderate | Self-funded |
| Shafaee et al. (2019) [ | 10 | Up to July 2018 | MTA vs. Biodentine vs. FS vs. FC in pulpotomy | Cochrane | 10 RCTs | SR & MA | Success rate (clinical and radiographic) | Low | NI |
| Shirvani et al. (2014 a) [ | 19 | Up to March 2013 | MTA vs. FC in pulpotomy | Modified van Tulder list [ | 19 RCTs | SR & MA | Success rate (clinical) | Moderate | Self-funded |
| Shirvani et al. (2014 b) [ | 4 | Up to March 2013 | MTA vs. CH in pulpotomy | Modified van Tulder list [ | 4 RCTs | SR & MA | Success rate (clinical and radiographic) | Moderate | NI |
| Smaïl-Faugeron et al. (2016) [ | Up to February 2015 | Indirect pulp capping Vs Pulpotomy | Cochrane | 8 Survey of dental prattise, 1 non-randomized study, 2 protocols of ongoing randomized trials | SR | Success rate (clinical and radiographic) | Low | NR | |
| Smaïl-Faugeron et al. (2018) [ | 87 | Up to August 2017 | MTA vs. Biodentine vs. FS vs. FC vs. Laser in pulpotomy | Cochrane | 87 RCTs | SR & MA | Success rate (clinical and radiographic) | High | NR |
| Subramanyam et al. (2017) [ | 8 | Up to May 2017 | Herbal medicines vs. standard pulpotomy | Criteria developed by the authors | 8 RCTs | SR | Success rate (clinical and radiographic) | Low | Self-funded |
| Tedesco et al. (2021) [ | 9 | Up to May 2020 | Best approach for deep caries lesion | Cochrane | 9 RCTs | SR & MA | Success rate (clinical) | Moderate | Self-funded |
CCTs—controlled clinical trials; CH—calcium hydroxide; FC—formocresol; FS—Ferric Sulfate; MA—Meta-Analysis; MTA—mineral trioxide aggregate; N—number of included studies; NRSI—Nonrandomized study of intervention; RCTs—randomized-clinical trials; SR—Systematic Review; ZOE—zinc oxide eugenol; NI—no information; NR—not reported. * Detailed information regarding the methodological quality assessment is present in Table 2.
Results of the methodological quality assessment via AMSTAR2.
| First Author | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | Review Quality |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ansari 2018 [ | Y | N | Y | PY | Y | Y | Y | PY | N/N | N | N/0 | N | N | N | N | Y | Critically Low |
| Asgary 2014 [ | Y | Y | Y | PY | Y | Y | N | Y | PY/0 | N | Y/0 | Y | Y | Y | Y | N | Moderate |
| Barcelos 2011 [ | Y | PY | Y | PY | Y | Y | PY | PY | PY/0 | N | 0/0 | 0 | Y | N | 0 | N | Moderate |
| Bossù 2020 [ | Y | PY | Y | N | Y | Y | Y | PY | PY/PY | N | 0/0 | 0 | Y | Y | 0 | Y | Low |
| Chandran 2020 [ | Y | PY | Y | PY | Y | Y | Y | PY | PY/0 | N | Y/0 | Y | Y | Y | Y | Y | High |
| Chugh 2020 [ | Y | PY | Y | PY | Y | Y | Y | PY | PY/0 | N | Y/0 | Y | Y | Y | Y | Y | High |
| Coll 2017 [ | Y | PY | Y | PY | Y | Y | PY | PY | PY/0 | N | Y/0 | Y | Y | Y | Y | Y | High |
| Coll 2020 [ | Y | PY | Y | PY | Y | Y | PY | PY | PY/PY | Y | Y/Y | Y | Y | Y | Y | N | High |
| De Coster 2013 [ | Y | PY | N | PY | Y | Y | PY | PY | N/N | N | 0/0 | 0 | N | Y | 0 | N | Critically Low |
| Duarte 2020 [ | Y | PY | N | PY | Y | Y | Y | PY | PY/0 | N | Y/0 | Y | Y | Y | Y | Y | Moderate |
| Gadallah 2018 [ | Y | PY | N | PY | Y | Y | PY | PY | PY/0 | N | Y/0 | Y | Y | Y | Y | Y | Low |
| Garrocho Rangel 2019 [ | Y | PY | N | PY | Y | Y | PY | N | PY/0 | N | 0/0 | 0 | Y | N | 0 | Y | Moderate |
| Ghajari 2008 [ | Y | PY | Y | PY | Y | Y | N | N | PY/0 | N | Y/0 | Y | Y | Y | Y | Y | Moderate |
| Junior 2018 [ | Y | Y | Y | PY | Y | Y | PY | PY | PY/0 | N | Y/0 | Y | Y | Y | Y | Y | High |
| Lin 2014 [ | Y | N | Y | PY | Y | Y | PY | N | PY/0 | N | Y/0 | Y | Y | Y | Y | Y | Moderate |
| Manchanda 2020 [ | Y | PY | Y | PY | Y | Y | Y | PY | PY/0 | N | N/0 | Y | Y | N | Y | Y | Low |
| Marghalani 2014 [ | Y | PY | Y | PY | Y | Y | N | PY | PY/0 | N | Y/0 | Y | Y | Y | N | Y | Moderate |
| Nagendrababu 2018 [ | Y | PY | Y | PY | Y | Y | Y | PY | PY/0 | N | Y/0 | Y | Y | Y | Y | N | Moderate |
| Najjar 2019 [ | Y | PY | Y | PY | Y | Y | Y | N | PY/PY | N | Y/Y | Y | Y | Y | Y | Y | Moderate |
| Nematollahi 2019 [ | Y | PY | N | PY | Y | Y | N | N | PY/N | N | Y/Y | Y | Y | Y | N | Y | Low |
| Nuvvula 2018 [ | Y | PY | Y | PY | Y | Y | N | PY | N/0 | N | 0/0 | 0 | N | N | 0 | Y | Low |
| Peng 2007 [ | N | PY | Y | PY | Y | Y | N | PY | PY/PY | N | Y/Y | Y | Y | Y | N | N | Moderate |
| Pintor 2016 [ | Y | PY | Y | PY | Y | Y | N | Y | Y/0 | N | 0/0 | 0 | Y | N | 0 | N | Moderate |
| Pozos-Guillen 2016 [ | Y | Y | Y | Y | Y | Y | N | Y | Y/0 | N | Y/0 | Y | Y | Y | Y | Y | Moderate |
| Da Rosa 2019 [ | N | PY | Y | PY | Y | Y | N | PY | Y/0 | N | Y/0 | Y | Y | Y | Y | Y | Moderate |
| Schwendicke 2016 [ | N | Y | N | Y | Y | Y | N | Y | Y/Y | N | Y/Y | Y | Y | Y | Y | Y | Moderate |
| Shafaee 2019 [ | N | N | Y | N | Y | Y | N | PY | Y/0 | N | Y/0 | N | Y | Y | Y | Y | Low |
| Shirvani 2014 [ | N | PY | Y | PY | Y | Y | N | Y | PY/0 | N | Y/0 | N | Y | N | Y | Y | Moderate |
| Shirvani 2014 (2) [ | Y | Y | Y | PY | Y | Y | N | PY | Y/0 | N | Y/0 | Y | Y | Y | Y | Y | Moderate |
| Smaïl-Faugeron 2016 [ | N | N | Y | N | Y | Y | N | N | PY/PY | N | 0/0 | 0 | Y | N | 0 | N | Low |
| Smaïl-Faugeron 2018 [ | Y | Y | Y | Y | Y | Y | Y | Y | Y/0 | Y | Y/0 | Y | Y | Y | Y | Y | High |
| Subramanyam 2017 [ | Y | Y | Y | PY | N | N | N | Y | Y/0 | N | 0/0 | 0 | N | N | 0 | N | Low |
| Tedesco 2021 [ | Y | Y | Y | Y | Y | Y | N | Y | PY/0 | N | Y/0 | Y | Y | Y | Y | Y | Moderate |
0—No meta-analysis conducted, N—No, Y—Yes, PY—Partial Yes. 1. Research questions and inclusion criteria? 2. Review methods established a priori? 3. Explanation of their selection literature search strategy? 4. Did the review authors use a comprehensive literature search strategy? 5. Study selection performed in duplicate? 6. Data selection performed in duplicate? 7. List of excluded studies and exclusions justified? 8. Description of the included studies in adequate detail? 9. Satisfactory technique for assessing the risk of bias (RoB)? 10. Report on the sources of funding for the studies included in the review? 11. If meta-analysis was performed, did the review authors use appropriate methods for statistical combination of results? 12. If meta-analysis was performed, did the review authors assess the potential impact of RoB? 13. RoB accounted when interpreting/discussing the results of the review? 14. Did the review authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed in the results of the review? 15. If they performed quantitative synthesis, was publication bias performed? 16. Did the review authors report any potential sources of conflict of interest, including funding sources?.